pharmacogenomics

Assurex Health Launches Collaboration with Canadian Mental Health Center

By Brad Webb / November 29, 2013 / 0 Comments

Our portfolio company Assurex Health just announced the creation of a partnership with Canada’s Center for Addiction and Mental Health (CAMH), one of the world’s leading research centers in the area of addiction and mental health and Canada’s largest mental health teaching hospital. CAMH will offer to Canadian citizens the firm’s pharmacogenomic test, GeneSight, which […]

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat_Boldhaber7718 -1200px

NAT GOLDHABER

Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

READ MORE
Brad_Webb8124 1200px crop

BRAD WEBB

Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

READ MORE
Randy_Hawks7690 -1200px

RANDY HAWKS

Randy Hawks is a co-founder of Claremont Creek Ventures.

READ MORE

Post Categories

Keywords

SVASE cleantech government policies power generation solar thermoelectric smartgrid angel investor chromosone screening Series B DOOH carried interest market uncertainty government funding words-of-wisdom cloud computing gene disorder testing awards healthcare exit energy conservation mentoring government programs market conditions swtching costs genetic screening innovation bioinformatics renewable energy private equity IPO stem cell energy storage early-stage Digital Healthcare greentech funding energy tech targeted customer segments bionics startups video M&A corporate venture funding Personalized Pharmacology

Archives